MDC
FY2026 EPS Estimate
$6.72
FY2026E EPS$6.72

Analyst Sentiment

Wall St. Consensus
Hold
18 analysts·Moderate coverage
53
Score
5 Buy (28%)10 Hold (56%)3 Sell (16%)
Rating Breakdown
Strong Buy
00%
Buy
528%
Hold
1056%
Sell
317%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$27.00
-57.1%
Consensus
$39.50
-37.3%
Bull
$44.00
-30.1%
12-Month Target Range18 analysts
$27.00$39.50$44.00
Current $62.98Consensus
Current Price
$62.98
Above Consensus
$23.48

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026E
Revenue Avg$5.67B
Low$5.67B
High$5.67B
EBITDA Avg$1.72B
Low$1.72B
High$1.72B
EBIT Avg$1.69B
Low$1.69B
High$1.69B
Net Income Avg$514M
Low$514M
High$514M
EPS Avg$6.72
Low$6.72
High$6.72
Analysts (Rev / EPS)1 / 1

Earnings Surprises

Recent Analyst Actions

Nov 3, 2023J.P. Morgan
Check Out 3 Consumer Stocks With Over 5% Dividend Yields From Wall Street's Most Accurate Analysts
Target:$39.50
-7.7%from $42.80
Nov 22, 2022J.P. Morgan
JP Morgan Downgrades M.D.C. Holdings to Underweight, Raises Price Target to $28
Target:$28.00
-10.0%from $31.11
Aug 1, 2022Raymond James
Raymond James Maintains Strong Buy on M.D.C. Holdings, Lowers Price Target to $44
Target:$44.00
+21.4%from $36.25
Jul 12, 2022J.P. Morgan
JP Morgan Maintains Neutral on M.D.C. Holdings, Lowers Price Target to $38
Target:$38.00
+6.7%from $35.63
Jun 17, 2022Wells Fargo
M.D.C. Holdings downgraded to Underweight from Equal Weight at Wells Fargo
Target:$27.00
-8.9%from $29.64
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.